KalVista Pharmaceuticals (KALV) Tax Rate (2025)
KalVista Pharmaceuticals' (KALV) quarterly Tax Rate came in at 3.8% in Q3 2025, down 72.88% quarter-over-quarter from 2.2% in Q2 2025.
KalVista Pharmaceuticals (KALV) Tax Rate (2025) Analysis & Trends
KalVista Pharmaceuticals has disclosed Tax Rate across 1 years of filings, most recently posting 3.8% for Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 5.61% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -3.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -3.80% |
| Jul 31, 2025 | -3.80% |
| Apr 30, 2025 | -2.20% |
| Apr 30, 2025 | -2.20% |